sulfadiazine has been researched along with prednisolone in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.83) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Sarkari, NB; Shukla, SK | 1 |
| Kourounakis, P; Selye, H; Szabo, S | 1 |
| Eggers, B; Strothmann, G | 1 |
| Linton, RG | 1 |
| Lakhanpal, V; Nirankari, VS; Schocket, SS | 1 |
| Elias, SJ; Holland, GN; Morhun, PJ; Weisz, JM | 1 |
| Lepage, P; Michez, D; Noël, E; Quintart, C | 1 |
| Davis, J; Ysasaga, JE | 1 |
| Biswas, J; Ganesh, SK; Narayana, KM; Sharma, S | 1 |
| Holtkamp, M; Klingebiel, R; Okuducu, AF; Ploner, CJ | 1 |
| Daneshjou, Kh; Jedari, AS; Maliky, Z | 1 |
| Azimzadeh, A; Dehghan, MH; Peyman, GA; Ramezani, A; Sadoughi, MM; Shahghadami, R; Soheilian, M; Yaseri, M | 1 |
| Aksoy, A; Oguz, M; Ozkan, M; Tanir, G; Yıldız, YT | 1 |
1 review(s) available for sulfadiazine and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for sulfadiazine and prednisolone
| Article | Year |
|---|---|
Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis.
Topics: Adult; Antibodies, Protozoan; Antiprotozoal Agents; Clindamycin; Dexamethasone; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; Immunoglobulin M; Intravitreal Injections; Male; Prednisolone; Prospective Studies; Pyrimethamine; Single-Blind Method; Sulfadiazine; Toxoplasmosis, Ocular; Treatment Outcome; Visual Acuity; Young Adult | 2011 |
22 other study(ies) available for sulfadiazine and prednisolone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
An epidemic of acute pyogenic (meningococcal) meningitis.
Topics: Adolescent; Adult; Child; Child, Preschool; Disease Outbreaks; Humans; India; Infant; Meningitis, Meningococcal; Middle Aged; Penicillins; Prednisolone; Sulfadiazine | 1975 |
Effect of pharmacologic conditioning on sulfadiazine toxicity and concentrations in plasma.
Topics: Adrenocorticotropic Hormone; Androstenols; Animals; Depression, Chemical; Desoxycorticosterone; Estradiol; Female; Ketosteroids; Kidney; Organ Size; Phenobarbital; Prednisolone; Pregnanediones; Pregnenolone Carbonitrile; Propionates; Rats; Spironolactone; Stimulation, Chemical; Sulfadiazine; Thyroxine; Triamcinolone | 1974 |
[Febrile exanthema after nitrofurantoin administration].
Topics: Aged; Drug Combinations; Drug Hypersensitivity; Exanthema; Female; Fever; Humans; Nitrofurantoin; Phenazopyridine; Prednisolone; Pyelonephritis; Sulfadiazine; Urinary Tract Infections | 1974 |
Prophylactic treatment of recurrent attacks of uveitis due to I. toxoplasmosis and 2. streptococci.
Topics: Chronic Disease; Humans; Penicillins; Prednisolone; Pyrimethamine; Streptococcal Infections; Sulfadiazine; Toxoplasmosis, Ocular; Uveitis | 1969 |
Clindamycin in the treatment of toxoplasmic retinochoroiditis.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Chorioretinitis; Clindamycin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prednisolone; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Ocular | 1983 |
Recurrent ocular toxoplasmosis in patients treated with systemic corticosteroids.
Topics: Adolescent; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Protozoan; Antidotes; Child; Chorioretinitis; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leucovorin; Male; Middle Aged; Prednisolone; Pyrimethamine; Recurrence; Sulfadiazine; Toxoplasma; Toxoplasmosis, Ocular | 1996 |
[Peripheral thrombopenic purpura associated with acquired toxoplasmosis].
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Child; Coccidiostats; Humans; Immunoglobulins, Intravenous; Male; Platelet Transfusion; Prednisolone; Purpura, Thrombocytopenic; Pyrimethamine; Spiramycin; Sulfadiazine; Toxoplasmosis | 1998 |
Frosted branch angiitis with ocular toxoplasmosis.
Topics: Adolescent; Animals; Antibodies, Protozoan; Chorioretinitis; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fluorescein Angiography; Humans; Prednisolone; Pyrimethamine; Retinal Diseases; Retinal Vessels; Sulfadiazine; Toxoplasma; Toxoplasmosis, Ocular; Vasculitis | 1999 |
Fuchs' heterochromic iridocyclitis following bilateral ocular toxoplasmosis.
Topics: Adult; Antiprotozoal Agents; Atrophy; Clindamycin; Drug Therapy, Combination; Female; Humans; Iridocyclitis; Iris; Prednisolone; Recurrence; Sulfadiazine; Toxoplasmosis, Ocular | 2004 |
Cerebral toxoplasmosis in a patient with common variable immunodeficiency.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Protozoan; Antiprotozoal Agents; Biopsy; Brain; Central Nervous System Neoplasms; Common Variable Immunodeficiency; Deglutition Disorders; Diagnosis, Differential; Dysarthria; False Negative Reactions; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Opportunistic Infections; Prednisolone; Pyrimethamine; Quadriplegia; Sulfadiazine; Toxoplasmosis, Cerebral | 2004 |
A 10 month old infant with nystagmus and strabismus.
Topics: Brain; Electroencephalography; Eye Movements; Fever; Humans; Infant; Leucovorin; Male; Nystagmus, Pathologic; Prednisolone; Pyrimethamine; Strabismus; Sulfadiazine; Tomography, X-Ray Computed; Toxoplasmosis | 2008 |
Acute disseminated encephalomyelitis associated with acute Toxoplasma gondii Infection.
Topics: Brain; Child; Coccidiostats; Encephalomyelitis, Acute Disseminated; Glucocorticoids; Humans; Male; Methylprednisolone; Prednisolone; Pyrimethamine; Spinal Cord; Sulfadiazine; Toxoplasma; Toxoplasmosis; Treatment Outcome | 2013 |